Healthcare worldwide does not have the relevant infrastructure to track and implement innovative model prices, they are largely reluctant to take innovative policies. Their systems are most often needed to make tough decisions on whether to provide patients with access to expensive pharmacological treatments while paying attention to their limited resources. The reason why they should absorb innovative pricing methods, is that they can overcome the challenges they face when trying to access funding for new drugs. This will allow the implementation of flexible pricing options to access maintenance prices in relation to the benefits it offers.
Some of the reasons why not many adoptions of flexible pricing solutions include :
- Inadequate patient compliance in real time
- Patient privacy
- A fragmented health care system
- The inability to use one size fits all customized platforms that can traverse all areas
- Inconsistencies in healthcare provider services.
These problems posed a threat to the possibility of patients not receiving care that could save their lives.
Our vision
To pioneer the delivery of sustainable and value-based health services, the generation of innovative evidence and patient empowerment across the health care industry.
Problem
- Barriers to innovative pricing and 'paying for performance
Healthcare systems are often required to make their own limited resources. Innovative pricing approaches have the ability to overcome the challenges faced by healthcare systems when assessing the funding of new drugs, to enable the implementation of 'flexible' pricing schemes to assess the price of treatment in relation to the benefits it delivers. Unfortunately, healthcare systems around the world lack the relevant infrastructure to track and implement innovative pricing agreements, and so reluctant to adopt such innovative policies. This results in novel pharmacological therapies being the burden on health systems and a barrier to reimbursement for manufacturers.
- Limitations of conventional real world evidence
Real world evidence (RWE) is playing an increasingly influential role in informing decision making within the healthcare industry and is crucial to informing value-based healthcare. Yet the delay of RWE outputs, the expenses of data access and the current methods of data collection. The lack of easily accessible and comprehensive RWE currently prevents stakeholders in healthcare to evaluate the real time performance and value provided by therapy in real life clinical practice as part of a value-based healthcare delivery system.
Solutions
- Reimburse
The Reimburse platform harnesses the benefits of automated 'smart contracts' and blockchain technology; facilitating the application of truly dynamic innovative pricing solutions between healthcare systems and manufacturers, in a secure and compliant fashion with minimal administrative burden. Use of the Reimburse platform will expedite integration, coordination and delivery of patient centric healthcare systems with a focus on improving patient outcomes while accelerating 'payment for value' mechanisms between payers and manufacturers using neutrally-enforceable agreements in peer to peer fashion.
- Insights
The Insights platform will extract anonymised patient level data from the Reimburse platform and health information systems to the world's first 'live' RWE database. Insights will provide a progressive transformation towards value-based healthcare delivery systems. The development of a 'live' evidence repository will allow the integration of knowledge back into the delivery system in real time to facilitate decision making, drug development and health related research. Patients will be incentivised to contribute their health information to the platform and will gain access to health information that is currently unattainable.
PLATFORM DIGIPHARM
Digipharm has a platform that is a decentralized public / private blocking solution that enables the delivery of value-based pricing agreements to stakeholders. It also collects and stores tangible evidence of patient data. The Digipharm platform also enables the delivery of personalized healthcare solutions.
PLATFORM FEATURES
DIGIPHARM The digipharm platform is a unique platform and has the following features namely; integration into existing IT stakeholder infrastructure, patient websites and applications, legal / regulatory / compliance mechanisms, smart contracts for innovative pricing agreements and task automation and interfaces for manufacturers / payers / providers.
CHARACTERISTIC OF DPH TOKEN
- DPH Supply: 100,000,000 Fixed (ERC-20)
- Code Ticker: DPH
- Decimal Place: 18
- Token Price 1.00 USD
DPH TOKEN SALE
- PRE - SALE: 15,000,000 DPH
- Base Price: 1.0 USD
- Pre-Sales Length: 4 Weeks
- Pre-Discount Sales: 35%
KEY SALES: 50,000,000 DPH
- Week 1: 25% is limited to 25 million tokens
- Week 2: 15% closed at 15 million tokens
- Week 3: 10% is limited to 10 million tokens
- Week 4: 1.00 USD
Any unsold token will be burned.
- Reference / Bounties - 1%
- Reservation / Bounties - 14%
- Team / Partner - 20%
- ICO - 65%
- Charitable Foundation - 0.5%
- Marketing - 4%
- Laws & Regulations - 15%
- Professional Services - 15.5%
- Product Development - 65%
Our Team
Our Advisors
Digipharm uses blockchain technology on their platform to enable and promote the distribution of universally available, safe and transparent medical data infrastructure. Maintenance and utility of this platform will provide the joint protection of advanced security measures that comply with the information management protocol. Digipharm strongly believes in strengthening patients with full ownership and custody of their personal data. This is the desired level of security in today's health care industry.
For more details about our ICO you can also visit our website address below :
- Website : https://www.digipharm.ch/
- Technical document : https://digipharm.ch/docs/DigipharmWP.pdf
- Twitter : https://twitter.com/DigipharmTeam
- Facebook : https://www.facebook.com/digipharmteam/
- Telegram : https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
Author Article : Boyambon07
ETH : 0xE4Dcb7142A7fB9E3090059B69CedfEb88B2D2690
Tidak ada komentar:
Posting Komentar